Small-cap stock soars 76% in 1 year; Motilal Oswal sees 26% more upside— a potential multibagger in the making?
Small-cap stock: Blue Jet Healthcare share price jumped over 6 per cent in intraday trade on the BSE on Wednesday, April 30, looking set to snap its three-day losing run after domestic brokerage firm Motilal Oswal Financial Services initiated coverage on the stock with a buy recommendation, suggesting the potential for multibagger returns. The small-cap stock opened at ₹ 690 against its previous close of ₹ 686.70 and rose over 6 per cent to an intraday high of ₹ 729.25. Around 11 AM, Blue Jet Healthcare share price traded 5.61 per cent higher at ₹ 725.20. Equity benchmark Sensex was flat at 80,293 at that time.
Blue Jet Healthcare share price has been on a roll over the last year, surging 76 per cent as of April 29 close.
Shares of Blue Jet Healthcare debuted on the Indian stock exchanges on November 1, 2023. In just about a year and a half, the stock has rallied 98.5 per cent from its issue price of ₹ 346. Based on today's high of ₹ 729.25, it has more than doubled investors' money, delivering multibagger returns of 111 per cent.
The small-cap stock recently hit its 52-week high of ₹ 968.75 on March 21 this year, whereas it hit a 52-week low of ₹ 346.70 on June 4 last year.
However, it has seen selling pressure in April. As of the previous session's close, the stock has suffered a loss of 22 per cent this month and is set to snap its five-month winning streak.
Despite stellar gains over the last year, domestic brokerage firm Motilal Oswal Financial Services believes the stock has more room to grow.
The brokerage firm has initiated coverage on the stock with a 'buy' recommendation. Motilal has given a target price of ₹ 865, implying a 26 per cent upside potential from the stock's April 29 close.
"With its niche product offerings in contrast media and pharmaceutical intermediaries and API (active pharmaceutical ingredient), Blue Jet Healthcare has been changing how the healthcare industry caters to the therapeutic needs of patients around the globe," Motilal Oswal noted.
"The company has established itself as a reliable supplier to its customers for the past three decades and is now working toward moving up the value chain by significantly increasing its investment in R&D (research and development)," the brokerage firm added.
Motilal said Blue Jet Healthcare's revenue growth will be driven by new products in iodinated and gadolinium contrast media, NCE intermediates, and a high-intensity sweetener variant.
The brokerage firm also said the PI/API segment is set for strong growth, with a ramp-up in supplies for Esperion's Bempedoic acid in the coming quarters.
Taking note of the existing products ramping up and new product launches, Motilal Oswal expects Blue Jet Healthcare to post a CAGR of nearly 27 per cent, 24 per cent and 19 per cent in revenues, EBITDA and PAT, respectively, over FY25-27E.
Motilal also expects a sharp uptick in the pharma Intermediaries segment, and an average EBITDAM of 35.1 per cent during FY25-27E.
On the valuation front, according to Motilal Oswal, the stock is trading at a PE (price-to-earnings) of nearly 28 times on FY27E EPS (earnings per share) of ₹ 24.7 and FY27E EV/ EBITDA (enterprise value to earnings before interest, taxes, depreciation and amortisation) of nearly 20 times.
Read all market-related news here
Read more stories by Nishant Kumar
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
an hour ago
- Time of India
Turf war in the clouds showers on the ground
Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Indian data centre companies are looking to attract neocloud firms such as Coreweave , Lambda Labs, Crusoe and Nebius, which offer high-end computing for generative artificial intelligence training at nearly one-third the price of hyperscalers like Amazon Web Services, Google Cloud and Microsoft by large investors, neoclouds, or 'babyscalers'—boutique operators offering specialised infrastructure and flexible GPU rentals—are fast snagging business from Microsoft Azure, AWS and Google Cloud. A study by digital infrastructure consultancy Uptime Institute showed that the average hourly cost of an Nvidia DGX H100 GPU system from a hyperscaler was $98, while neocloud players offer it at about $34—a 66% attractive prices, along with cheap data centre space and power in India, make a powerful case for neocloud companies to invest here, industry experts said. Sharad Agarwal, CEO of Chennai-based data centre services provider Sify Infinit Spaces, said neocloud companies are watching the Indian market keenly, especially because of the world's lowest rack rentals and power costs here. Many neocloud operators evolved from Bitcoin mining, gaming and high-frequency trading backgrounds. As AI chips grew in demand post ChatGPT's release in 2022, these firms quickly amassed thousands of chips to offer on Wall Street financiers have created a lucrative debt market for the neocloud firms which use the funds to acquire thousands of Nvidia chips and further rent out on hourly/monthly usage neocloud firms are cash rich. Large private equity firms like Blackstone, Carlyle and BlackRock have pumped in $11 billion in this new cohort of companies. Coreweave made an impressive $23-billion debut on Nasdaq this to semiconductor research firm Semianalysis, besides the four neocloud leaders, there are 131 emerging players in the segment globally who offer GPU rentals at discounted Infinit Spaces has introduced a pay-per-use pricing model, offering power and rack space to neocloud companies deploying GPU clusters in India. 'Our pay-per-use pricing model is a disruptor to the data centre industry,' Agarwal said. 'Huge entry cost is a barrier for emerging cloud infra firms to expand in foreign markets, and hence this pricing structure could derisk companies' fixed cost.'Hiranandani Group's Yotta Data Services – which by itself is India's sovereign neocloud -- said it has listed 8000 Nvidia H100 GPUs on Nvidia's marketplace alongside Lambda Labs, Coreweave and Nebius to offer their GPUs-as-a-service. 'This shift from hyperscalers to AI-specialised clouds is not just a competitive realignment—it's critical for democratising access to high-performance compute and accelerating innovation,' said Sunil Gupta, cofounder, CEO and managing director of Yotta Data Services, which has deployed its own sovereign neocloud with IndiaAI Mission, NIC, and Group's Blackbox said it is tapping North America and Europe expansion of neocloud firms to provide cabling, design, and construction services, and participate in their 'multi-billion gigawatt-scale expansion.'Blackbox is also pursuing global rollouts of gigawatt-scale campuses of neocloud operators for a range of services. 'These include structured cabling, data centre design, and turnkey construction services for both greenfield and retrofit projects,' said Sanjeev Verma, president and CEO of Black current discussions are focused on North America and Europe markets, expansion in India is not a question of if, but when, Verma added. CtrlS Datacenters is also in early talks with neocloud firms 'to deploy GPU clusters in India, driven by increasing AI model training and inference workloads, especially in sectors like BFSI, healthcare and manufacturing,' said Ranjit Metrani, president, managed services, at CtrlS say it is the right time for India's infrastructure players to strike long-term partnerships with neocloud firms as the industry is growing rapidly and India is evolving to be one of the largest markets for AI use. 'Neocloud companies are gaining market share globally at an incredibly fast pace comparable to the early growth of hyperscalers,' said Jitesh Karlekar, director-research at real estate research and advisory firm JLL.'This is a fundamental shift in the cloud business model… Neocloud firms are architected for the AI-native era. They offer more specialised infrastructure, lower latency, flexible pricing, and are often better optimised for high-performance computing workloads.' Therefore, it is crucial for India's infrastructure players to catch on this momentum early,' he said.
Time of India
an hour ago
- Time of India
ET Graphics: AI has seen ‘unprecedented' growth
One of the most striking aspects of change is that the most valuable gobal companies are not telecommunications players any more, but technology companies. Tired of too many ads? Remove Ads Mary Meeker, called the 'Queen of the Internet', published her first trends report in five years, focused on AI. The report, published last week, used the word 'unprecedented' 64 currently general partner at Bond Capital and a former managing director at Morgan Stanley, underscored how fast AI is changing the world as we know of the most striking aspects of change is that the most valuable gobal companies are not telecommunications players any more, but technology companies. India has a place in the report too with Reliance Industries the sole Indian enterprise to figure in the Top 30 technology companies in 2025, along with giants such as Google, Nvidia and report, apart from showcasing the growth of AI, also gives a glimpse into what the next era of internet would look like and where countries like India stand. Swathi Moorthy dives deep to bring out the nuggets.
Economic Times
an hour ago
- Economic Times
High input costs cloud outlook for fertiliser, chemical companies
ET Intelligence Group: The ET Fertiliser and ET Chemical indices have each gained nearly 19% over the past three months, buoyed by recovery in the broader market. However, retaining these gains will be challenging given the input cost inflation and slow export demand amid tariff-related measures. Rising prices of raw materials such as rock phosphate and sulphur have affected margins. Low inventory levels of key fertilisers including di-ammonium phosphate (DAP) may offer support given the potential restocking-led demand. For the chemical sector, moderating exports and falling prices remain a concern. ADVERTISEMENT In April 2025, the government increased subsidies on phosphates and sulphur by 45% and 48% to make fertilisers affordable to farmers. This, however, is likely to cover higher input costs only partially. According to Elara Capital, soaring prices of raw materials such as rock phosphate and sulphur-key inputs for phosphoric acid, which finds use in fertilisers and soil management-are expected to narrow margin spreads by up to 30% for fertiliser makers even after taking the government subsidies into account. On the positive side, Elara pointed out that inventory levels of key fertilisers like DAP and urea are at its second lowest level in the past six years, pointing to potential restocking-led demand. Price trends remain mixed across the chemicals basket. According to Kotak Securities, refrigerant prices remain firm, but most petrochemical and battery materials are under pressure. Soda ash shows no signs of recovery, and while phenol prices have rebounded modestly, they still remain below historical averages. India's organic and inorganic chemical exports fell 21% month-on-month and 9% year-on-year in April 2025. Globally, the demand outlook remains weak. Kotak highlights a sharp fall in India's chemical exports in April and soft crop prices across major commodities like corn, soybean, and wheat. International agrochemical companies have guided for flat growth in CY25, pointing to continued headwinds. "There's no broad-based recovery in prices yet," Kotak Securities added, citing continued oversupply from China and weak global pricing across chemical categories. Motilal Oswal Financial Services considers Atul and Vinati Organics as top picks. "Atul's end-user demand improved in FY25 with key projects like the 50 KTPA liquid epoxy resin plant commissioned," the brokerage mentioned in a report, assigning a target price of ₹8,450. Vinati Organics has commissioned plants for antioxidants (AO) and other products. Its revenue from AOs grew to ₹220 crore in FY25 from ₹130 crore in FY24, making it the largest double-integrated AO manufacturer in India. Motilal Oswal has assigned a target price of ₹2,195, reflecting a healthy long-term growth outlook despite supply risks from China. The stocks of Atul and Vinati were last traded at ₹7,457.6 and ₹1,875 on Monday on the BSE. ADVERTISEMENT In coming quarters, sector performance will hinge on input cost trends, crop price recovery, and rebound in export markets. Analysts maintain a cautious stance, projecting margin stress despite supportive policy measures. (You can now subscribe to our ETMarkets WhatsApp channel)
